Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease

Liver International

Volumn 32, Issue 4, 2012, Pages 629-634

  Franzini, Maria ^a,c   Fornaciari, Irene ^a   Fierabracci, Vanna ^b   Elawadi, Hassan Aziz ^b   Bolognesi, Valeria ^b   Maltinti, Simona ^b   Ricchiuti, Angelo ^b   De Bortoli, Nicola ^b   Marchi, Santino ^b   Pompella, Alfonso ^b   Passino, Claudio ^a,c   Emdin, Michele ^c   Paolicchi, Aldo ^b,c  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

Author keywords

Biomarker; Chromatography; Chronic viral hepatitis C; Gamma glutamyltransferase fractions; Non alcoholic fatty liver disease

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS C, CHRONIC; HUMANS; ITALY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; ROC CURVE;

EID: 84858283833     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02673.x     Document Type: Article

References (32)

1. Bedogni G, Miglioli L, Masutti F et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42: 44-52.
2. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008; 28: 339-50.
3. De Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008; 48(Suppl.1): S104-12.
4. Lee DS, Evans JC, Robins SJ et al. Gamma glutamyltransferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart study. Arterioscler Thromb Vasc Biol 2007; 27: 127-33.
5. Loria P, Adinolfi LE, Bellentani S et al. NAFLD Expert Committee of the Associazione Italiana per lo studio del Fegato. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis 2010; 42: 272-82.
6. Fierbinteanu-Braticevici C, Dina I, Petrisor A et al. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol 2010; 16: 4784-91.
7. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38: 263-355.
8. Fraser A, Ebrahim S, Smith GD, Lawlor DA. A comparison of associations of alanine aminotransferase and gamma-glutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes. Hepatology 2007; 46: 158-65.
9. Haring R, Wallaschofski H, Nauck M et al. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology 2009; 50: 1403-11.
10. Itoh S, Nakajima M. Liver gamma-glutamyl-transferase activity in viral liver-disease. Digestion 1986; 33: 121-5.
11. Bedogni G, Bellentani S, Miglioli L et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6: 33-39.
12. Hwang SJ, Luo JC, Lai CR et al. Clinical, virological and pathological significance of elevated serum gamma-glutamyltranspeptidase in patients with chronic hepatitis C. Zhonghua Yi Xue Za Zhi (Taipei) 2000; 63: 527-35.
13. Vardar R, Vardar E, Demiri S et al. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis? Hepatogastroenterology 2009; 56: 1459-65.
14. Imbert-Bismut F, Ratziu V, Pieroni L et al.; MULTIVIRC Group. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-75.
15. Shaheen AA, Wan AF, Myers RP. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol 2007; 102: 2589-600.
16. Halfon P, Munteanu M, Poynard T. FibroTest-ActiTest as a non-invasive marker of liver fibrosis. Gastroenterol Clin Biol 2008; 32: 22-39.
17. Franzini M, Bramanti E, Ottaviano V et al. A high performance gel filtration chromatography method for gamma-glutamyltransferase fraction analysis. Anal Biochem 2008; 374: 1-6.
18. Franzini M, Ottaviano V, Fierabracci V et al. Fractions of plasma gamma-glutamyltransferase in healthy individuals: reference values. Clin Chim Acta 2008; 395: 188-9.
19. Franzini M, Paolicchi A, Fornaciari I et al. Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. Clin Chem Lab Med 2010; 48: 713-7.
20. Franzini M, Corti A, Martinelli B et al. Gamma-glutamyltransferase activity in human atherosclerotic plaques-biochemical similarities with the circulating enzyme. Atherosclerosis 2009; 202: 119-27.
21. Schellenberg F, Schwan R, Mennetrey L et al. Dose effect relation between daily ethanol intake in the range 0-70 grams and %CDT value: validation of a cut-off value. Alcohol Alcohol 2005; 40: 531-4.
22. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-45.
23. Poynard T, Ratziu V, Naveau S et al. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol 2005; 4: 10-24.
24. Ryu S, Chang Y, Woo HY et al. Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middleaged Korean men. Metabolism 2010; 59: 683-9.
25. Lim JS, Lee DH, Park JY, Jin SH, Jacobs DR Jr. A strong interaction between serum gammaglutamyltransferase and obesity on the risk of prevalent type 2 diabetes: results from the Third National Health and Nutrition Examination Survey. Clin Chem 2007; 53: 1092-8.
26. Fraser A, Harris R, Sattar N et al. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care 2009; 32: 741-50.
27. Emdin M, Passino C, Michelassi C et al. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J 2001; 22: 1802-7.
28. Ruttmann E, Brant LJ, Concin H et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality. An investigation in a cohort of 163, 944 Austrian adults. Circulation 2005; 112: 2130-7.
29. Fraser A, Harris R, Sattar N et al. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol 2007; 27: 2729-35.
30. Paolicchi A, Minotti G, Tonarelli P et al. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation - a potential mechanism in atherosclerosis. J Investig Med 1999; 47: 151-60.
31. Paolicchi A, Emdin M, Ghliozeni E et al. Human atherosclerotic plaques contain gammaglutamyltranspeptidase enzyme activity [Images in cardiovascular medicine]. Circulation 2004; 109: 1440.
32. Emdin M, Passino C, Donato L, Paolicchi A, Pompella A. Serum gamma-glutamyltransferase as a risk factor of ischemic stroke might be independent of alcohol consumption. Stroke 2002; 33: 1163-4.